Epigallocatechin-3-gallate-induced free-radical production upon adipogenic differentiation in bovine bone-marrow mesenchymal stem cells

Cell and Tissue Research

Volumn 362, Issue 1, 2015, Pages 87-96

  Jeong, Jin Young ^a   Park, Mi Na ^a   Cho, Eun Seok ^a   Jang, Hyun Jun ^c   Park, Sungkwon ^b   Lee, Hyun Jeong ^a  

^a National Institute of Animal Science   (South Korea)

^b Sejong University   (South Korea)

^c Dankook University   (South Korea)

Author keywords

Adipogenic differentiation; Bone marrow mesenchymal stem cells; Bovine; Epigallocatechin 3 gallate; Free radicals

Indexed keywords

ACYL COENZYME A DESATURASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; EPIGALLOCATECHIN GALLATE; FREE RADICAL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; CATECHIN; TEA;

ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BOVINE; CELL DIFFERENTIATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FETUS; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETIC CODE; LONG TERM EXPOSURE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; S PHASE CELL CYCLE CHECKPOINT; ANALOGS AND DERIVATIVES; ANIMAL; BONE MARROW; CYTOLOGY; DRUG EFFECTS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; TEA;

ADIPOGENESIS; ANIMALS; BONE MARROW; CATECHIN; CATTLE; CELL DIFFERENTIATION; FREE RADICALS; HUMANS; MESENCHYMAL STROMAL CELLS; REACTIVE OXYGEN SPECIES; TEA;

EID: 84941875893     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-015-2191-y     Document Type: Article

References (43)

1. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD, Gimble JM (2004) Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6:7–14
2. Bylund J, Brown KL, Movitz C, Dahlgren C, Karlsson A (2010) Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for? Free Radic Biol Med 49:1834–1845
3. Byun JK, Yoon BY, Jhun JY, Oh HJ, Kim EK, Min JK, Cho ML (2014) Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4(+) T-cell subsets. Immunol Lett 157:51–59
4. Chan CY, Wei L, Castro-Muñozledo F, Koo WL (2011) (−)-Epigallocatechin-3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression. Life Sci 89:779–785
5. D’Autréaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813–824
6. Eruslanov E, Kusmartsev S (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol Biol 594:57–72
7. Farabegoli F, Papi A, Orlandi M (2011) (−)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci Rep 31:99–108
8. Findeisen HM, Gizard F, Zhao Y, Qing H, Heywood EB, Jones KL, Cohn D, Bruemmer D (2011) Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler Thromb Vasc Biol 31:851–860
9. Glynn MW, McAllister AK (2006) Immunocytochemistry and quantification of protein colocalization in cultured neurons. Nat Protoc 1:1287–1296
10. Graugnard DE, Piantoni P, Bionaz M, Berger LL, Faulkner DB, Loor JJ (2009) Adipogenic and energy metabolism gene networks in longissimus lumborum during rapid post-weaning growth in Angus and Angus x Simmental cattle fed high-starch or low-starch diets. BMC Genomics 10:142
11. Hsuuw YD, Chan WH (2007) Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann N Y Acad Sci 1095:428–440
12. Hung PF, Wu BT, Chen HC, Chen YH, Chen CL, Wu MH, Liu HC, Lee MJ, Kao YH (2005) Antimitogenic effect of green tea (−)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways. Am J Physiol Cell Physiol 288:C1094–C1108
13. James AW (2013) Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica (Cairo) 2013:684736
14. Jeong JY, Suresh S, Jang M, Park MN, Gobianand K, You S, Yeon SH, Lee HJ (2014) Epigallocatechin-3-gallate suppresses the lipid deposition through the apoptosis during differentiation in bovine bone marrow mesenchymal stem cells. Cell Biol Int 39:52–64
15. Kaminskyy VO, Zhivotovsky B (2014) Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal 21:86–102
16. Khanna RD, Karki K, Pande D, Negi R, Khanna RS (2014) Inflammation, free radical damage, oxidative stress and cancer. Interdiscip J Microinflammation 1:109
17. Kim H, Sakamoto K (2012) (−)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3K/Akt pathways. Cell Biol Int 36:147–153
18. Kim SJ, Lee JH, Kim BS, So HS, Park R, Myung NY, Um JY, Hong SH (2012) (−)-Epigallocatechin-3-gallate protects against NO-induced ototoxicity through the regulation of caspase- 1, caspase-3, and NF-κB activation. PLoS One 7:e43967
19. Klaus S, Pültz S, Thöne-Reineke C, Wolfram S (2005) Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes 29:615–623
20. Ku HC, Chang HH, Liu HC, Hsiao CH, Lee MJ, Hu YJ, Hung PF, Liu CW, Kao YH (2009) Green tea (−)-epigallocatechin gallate inhibits insulin stimulation of 3T3-L1 preadipocyte mitogenesis via the 67-kDa laminin receptor pathway. Am J Physiol Cell Physiol 297:C121–C132
21. Lee H, Bae S, Yoon Y (2013) The anti-adipogenic effects of (−)epigallocatechin gallate are dependent on the WNT/β-catenin pathway. J Nutr Biochem 24:1232–1240
22. Li GX, Chen YK, Hou Z, Xiao H, Jin H, Lu G, Lee MJ, Liu B, Guan F, Yang Z, Yu A, Yang CS (2010) Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 31:902–910
23. Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44:479–496
24. MacDougald OA, Burant CF (2005) Fickle factor foils fat fate. Nat Cell Biol 7:543–545
25. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I (2014) Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Br J Nutr 111:1263–1271
26. Moon HS, Lee HG, Choi YJ, Kim TG, Cho CS (2007) Proposed mechanisms of (−)-epigallocatechin-3-gallate for anti-obesity. Chem Biol Interact 167:85–98
27. Navarro-Yepes J, Burns M, Anandhan A, Khalimonchuk O, del Razo LM, Quintanilla-Vega B, Pappa A, Panayiotidis MI, Franco R (2014) Oxidative stress, redox signaling, and autophagy: cell death versus survival. Antioxid Redox Signal 21:66–85
28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
29. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M (2006) Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibROSis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55:2502–2509
30. Rayalam S, Della-Fera MA, Baile CA (2008) Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 19:717–726
31. Renno WM, Al-Maghrebi M, Alshammari A, George P (2013) (−)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury. Neurochem Int 62:221–231
32. Saito Y, Nishio K, Ogawa Y, Kimata J, Kinumi T, Yoshida Y, Noguchi N, Niki E (2006) Turning point in apoptosis/necrosis induced by hydrogen peroxide. Free Radic Res 40:619–630
33. Schreml S, Babilas P, Fruth S, Orsó E, Schmitz G, Mueller MB, Nerlich M, Prantl L (2009) Harvesting human adipose tissue-derived adult stem cells: resection versus liposuction. Cytotherapy 11:947–957
34. Shin J, Li B, Davis ME, Suh Y, Lee K (2009) Comparative analysis of fatty acid-binding protein 4 promoters: conservation of peroxisome proliferator-activated receptor binding sites. J Anim Sci 87:3923–3934
35. Simmons DJ, Seitz P, Kidder L, Klein GL, Waeltz M, Gundberg CM, Tabuchi C, Yang C, Zhang RW (1991) Partial characterization of rat marrow stromal cells. Calcif Tissue Int 48:326–334
36. Sung HY, Hong CG, Suh YS, Cho HC, Park JH, Bae JH, Park WK, Han J, Song DK (2010) Role of (−)-epigallocatechin-3-gallate in cell viability, lipogenesis, and retinol-binding protein 4 expression in adipocytes. Naunyn Schmiedebergs Arch Pharmacol 382:303–310
37. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40
38. Vigouroux C, Caron-Debarle M, Le Dour C, Magré J, Capeau J (2011) Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol 43:862–876
39. Wang X, Hao MW, Dong K, Lin F, Ren JH, Zhang HZ (2009) Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Arch Pharm Res 32:1263–1269
40. Weinreb O, Amit T, Mandel S, Youdim MB (2009) Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 4:283–296
41. Wu BT, Hung PF, Chen HC, Huang RN, Chang HH, Kao YH (2005) The apoptotic effect of green tea (−)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the Cdk2 pathway. J Agric Food Chem 53:5695–5701
42. Yang J, Li L, Tan S, Jin H, Qiu J, Mao Q, Li R, Xia C, Jiang ZH, Jiang S, Liu S (2012) A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection. Fitoterapia 83:348–355
43. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295